from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3253c/-

LFCtreatmentdescriptionclass of inhibitor

-0.595

Amikacinug/mL Amikacintranslation

-0.430

Cap5-10ug/mL Capreomycintranslation

-0.422

Rox10-50 ug/mL Roxithromycintranslation

0.031

SM2-5 ug/mL Streptomycintranslation

0.211

Tet5-10 ug/mL Tetracyclinetranslation

0.341

Rif0.2-5ug/mL Rifampicintranscription

-0.498

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.085

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.030

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.283

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.708

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.855

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.378

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.949

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.107

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.255

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.040

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.060

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.917

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.172

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.419

KCN5-20 ug/mL Potassium cyaniderespiration

-0.543

NaN30.2-2 mM Sodium aziderespiration

-0.355

Nigericin50 uM Nigericinrespiration

0.566

TRC10-150 ug/mL Triclosanrespiration

0.169

TRZ10-25 ug/mL Thioridazinerespiration

-0.558

Valinomycin0.5-10 uM Valinomycinrespiration

-2.045

ZnSO42 mM ZnSO4respiration

0.174

menadione6-10 ug/mL Menadionerespiration

0.225

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.056

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.493

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.765

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.222

NRP_1Non-replicating persistence stage 1dosRassociated

0.207

Amp0.2mg/mL AmpicillincellWall

0.086

Cephalexin20-100 ug/mL CephalexincellWall

-0.296

Cerulenin0.32-5 ug/mL CerulenincellWall

1.152

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.240

EMB10-20 ug/mL EthambutolcellWall

0.145

Eta12-40 ug/mL EthionamidecellWall

0.150

INH0.2-0.4 ug/mL IsoniazidcellWall

0.608

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.273

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.092

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.433

BZA0.12 mg/mL BenzamidearomaticAmides

0.241

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.114

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.048

H2O24 mM hydrogen peroxideDNAdamaging

-0.873

Levo10 ug/mL LevofloxacinDNAdamaging

0.088

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.213

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.001

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.674

UVUV-irradiationDNAdamaging

0.417

ARP41-4 ug/mL Antitubercular compound ARP4?

0.211

Antimycin12.5-50 ug/mL Antimycin A?

-0.627

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.656

PA_110-50 ug/mL Antitubercular compound PA-1?

0.815

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.570

PA8240.2-2 ug/mL PA-824?

1.110

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.590

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.957

Verapamil50 uM Verapamil?

-0.667

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.786

methoxatin10-20 ug/mL Methoxatin?